Heidelberg Pharma AG HPHA-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 07/23/21 CEST
7.02quote price arrow down-0.15 (-2.09%)
52 week range
3.09 - 9.70

...

Loading . . .
  • Open7.04
  • Day High7.04
  • Day Low7.02
  • Prev Close7.15
  • 52 Week High9.70
  • 52 Week High Date02/18/21
  • 52 Week Low3.09
  • 52 Week Low Date11/02/20

Key Stats

  • Market Cap259.86M
  • Shares Out31.07M
  • 10 Day Average Volume4,653.27
  • Dividend-
  • Dividend Yield-
  • Beta-1.3
  • YTD % Change0.57

KEY STATS

  • Open7.04
  • Day High7.04
  • Day Low7.02
  • Prev Close7.15
  • 52 Week High9.70
  • 52 Week High Date02/18/21
  • 52 Week Low3.09
  • 52 Week Low Date11/02/20
  • Market Cap259.86M
  • Shares Out31.07M
  • 10 Day Average Volume4,653.27
  • Dividend-
  • Dividend Yield-
  • Beta-1.3
  • YTD % Change0.57

RATIOS/PROFITABILITY

  • EPS (TTM)-0.71
  • P/E (TTM)-9.89
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Heidelberg Pharma AG

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Heidelberg Pharma AG, formerly Wilex AG, is a Germany-based company engaged in the biopharmaceuticals sector. The Company focuses on the research and development of therapy treatments for oncology area. It aims at applying toxin Amanitin into cancer therapies using its Antibody Targeted Amanitin Conjugate (ATAC) technology. The Company’s pipeline includes a number of drug candidates, such as HDP-101, a B-cell maturation antigen ATAC for multiple myeloma; PSMA-ATAC...
Address
Schriesheimer Strasse 101
Ladenburg
68526
Germany